BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18689361)

  • 1. Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III.
    Zheng C; Khoo C; Furtado J; Ikewaki K; Sacks FM
    Am J Clin Nutr; 2008 Aug; 88(2):272-81. PubMed ID: 18689361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL.
    Gill JM; Brown JC; Caslake MJ; Wright DM; Cooney J; Bedford D; Hughes DA; Stanley JC; Packard CJ
    Am J Clin Nutr; 2003 Jul; 78(1):47-56. PubMed ID: 12816770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma concentrations of lipoprotein(a) during a low-fat, high-carbohydrate diet are associated with increased plasma concentrations of apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins.
    Shin MJ; Blanche PJ; Rawlings RS; Fernstrom HS; Krauss RM
    Am J Clin Nutr; 2007 Jun; 85(6):1527-32. PubMed ID: 17556688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.
    Zheng C; Khoo C; Ikewaki K; Sacks FM
    J Lipid Res; 2007 May; 48(5):1190-203. PubMed ID: 17314277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial.
    Furtado JD; Campos H; Appel LJ; Miller ER; Laranjo N; Carey VJ; Sacks FM
    Am J Clin Nutr; 2008 Jun; 87(6):1623-30. PubMed ID: 18541549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low-fat, high-complex carbohydrate diet supplemented with long-chain (n-3) fatty acids alters the postprandial lipoprotein profile in patients with metabolic syndrome.
    Jiménez-Gómez Y; Marín C; Peérez-Martínez P; Hartwich J; Malczewska-Malec M; Golabek I; Kiec-Wilk B; Cruz-Teno C; Rodríguez F; Gómez P; Gómez-Luna MJ; Defoort C; Gibney MJ; Pérez-Jiménez F; Roche HM; López-Miranda J
    J Nutr; 2010 Sep; 140(9):1595-601. PubMed ID: 20631323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.
    Zheng C; Khoo C; Furtado J; Sacks FM
    Circulation; 2010 Apr; 121(15):1722-34. PubMed ID: 20368524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High carbohydrate and high monounsaturated fatty acid diets similarly affect LDL electrophoretic characteristics in men who are losing weight.
    Archer WR; Lamarche B; St-Pierre AC; Mauger JF; Dériaz O; Landry N; Corneau L; Després JP; Bergeron J; Couture P; Bergeron N
    J Nutr; 2003 Oct; 133(10):3124-9. PubMed ID: 14519795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in plasma apolipoprotein C-III levels are strong correlates of the triglyceride response to a high-monounsaturated fatty acid diet and a high-carbohydrate diet.
    Archer WR; Desroches S; Lamarche B; Dériaz O; Landry N; Fontaine-Bisson B; Bergeron J; Couture P; Bergeron N
    Metabolism; 2005 Oct; 54(10):1390-7. PubMed ID: 16154441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
    Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.
    Furtado JD; Campos H; Sumner AE; Appel LJ; Carey VJ; Sacks FM
    Am J Clin Nutr; 2010 Oct; 92(4):714-22. PubMed ID: 20826623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of reduced-fat diets with different fatty acid compositions on serum lipoprotein lipids and apolipoproteins.
    Aro A; Pietinen P; Valsta LM; Turpeinen AM; Ehnholm C; Dougherty RM; Iacono JM
    Public Health Nutr; 1998 Jun; 1(2):109-16. PubMed ID: 10933407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of endothelial function are modulated by dietary monounsaturated fat.
    Pérez-Jiménez F; Castro P; López-Miranda J; Paz-Rojas E; Blanco A; López-Segura F; Velasco F; Marín C; Fuentes F; Ordovás JM
    Atherosclerosis; 1999 Aug; 145(2):351-8. PubMed ID: 10488963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins--the Jerusalem Nutrition Study. II. Monounsaturated fatty acids vs carbohydrates.
    Berry EM; Eisenberg S; Friedlander Y; Harats D; Kaufmann NA; Norman Y; Stein Y
    Am J Clin Nutr; 1992 Aug; 56(2):394-403. PubMed ID: 1636617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between smoking and the Sstl polymorphism of the apo C-III gene determines plasma lipid response to diet.
    Pérez-Martínez P; Gómez P; Paz E; Marín C; Gavilán Moral E; López-Miranda J; Ordovas JM; Fernandez de la Puebla RA; Pérez-Jiménez F
    Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4):237-43. PubMed ID: 11837227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein compositional changes in the fasting and postprandial state on a high-carbohydrate low-fat and a high-fat diet in subjects with noninsulin-dependent diabetes mellitus.
    O'Brien T; Nguyen TT; Buithieu J; Kottke BA
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1345-51. PubMed ID: 8077331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice.
    Merkel M; Velez-Carrasco W; Hudgins LC; Breslow JL
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13294-9. PubMed ID: 11606787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.